US Stock MarketDetailed Quotes

Context Therapeutics (CNTX)

Watchlist
  • 2.160
  • -0.170-7.30%
Close May 15 16:00 ET
  • 2.200
  • +0.040+1.85%
Post 18:34 ET
198.46MMarket Cap-5.14P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Context Therapeutics (CNTX) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2026
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
68.99%9.34M
32.68%39.7M
220.26%13.8M
-43.26%10.61M
215.95%9.76M
44.61%5.53M
19.35%29.92M
-37.83%4.31M
202.59%18.7M
-41.64%3.09M
Selling and administrative expenses
12.70%2.33M
8.64%7.85M
9.60%1.96M
0.65%1.89M
13.14%1.93M
11.67%2.07M
-0.92%7.22M
9.85%1.79M
10.67%1.88M
-6.96%1.7M
-General and administrative expense
12.70%2.33M
8.64%7.85M
9.60%1.96M
0.65%1.89M
13.14%1.93M
11.67%2.07M
-0.92%7.22M
9.85%1.79M
10.67%1.88M
-6.96%1.7M
Research and development costs
102.58%7.02M
40.33%31.86M
370.17%11.84M
-48.16%8.72M
465.56%7.83M
75.50%3.46M
27.66%22.7M
-52.50%2.52M
275.13%16.83M
-59.99%1.38M
Operating profit
-68.99%-9.34M
-32.68%-39.7M
-220.26%-13.8M
43.26%-10.61M
-215.95%-9.76M
-44.61%-5.53M
-19.35%-29.92M
37.83%-4.31M
-202.59%-18.7M
41.64%-3.09M
Net non-operating interest income expense
-45.74%520.14K
5.57%3.38M
-29.21%682.48K
-32.96%833.77K
7.57%903.77K
529.15%958.52K
174.94%3.2M
329.00%964.04K
328.21%1.24M
186.47%840.15K
Non-operating interest income
-45.74%520.14K
5.57%3.38M
-29.21%682.48K
-32.96%833.77K
7.57%903.77K
529.15%958.52K
174.94%3.2M
329.00%964.04K
328.21%1.24M
186.47%840.15K
Other net income (expense)
2,256.56%143.09K
14,138.59%200.47K
2,676.16%96.56K
3,978.76%83.47K
543.43%27.08K
-297.88%-6.64K
97.43%-1.43K
105.66%3.48K
-114.00%-2.15K
50.05%-6.11K
Other non- operating income (expenses)
2,256.56%143.09K
14,138.59%200.47K
2,676.16%96.56K
3,978.76%83.47K
543.43%27.08K
-297.88%-6.64K
97.43%-1.43K
105.66%3.48K
-114.00%-2.15K
50.05%-6.11K
Income before tax
-89.65%-8.68M
-35.17%-36.12M
-289.65%-13.03M
44.48%-9.69M
-291.55%-8.83M
-24.80%-4.58M
-11.52%-26.73M
50.62%-3.34M
-197.21%-17.46M
55.01%-2.25M
Income tax
Net income
-89.65%-8.68M
-35.17%-36.12M
-289.65%-13.03M
44.48%-9.69M
-291.55%-8.83M
-24.80%-4.58M
-11.52%-26.73M
50.62%-3.34M
-197.21%-17.46M
55.01%-2.25M
Net income continuous Operations
-89.65%-8.68M
-35.17%-36.12M
-289.65%-13.03M
44.48%-9.69M
-291.55%-8.83M
-24.80%-4.58M
-11.52%-26.73M
50.62%-3.34M
-197.21%-17.46M
55.01%-2.25M
Minority interest income
Net income attributable to the parent company
-89.65%-8.68M
-35.17%-36.12M
-289.65%-13.03M
44.48%-9.69M
-291.55%-8.83M
-24.80%-4.58M
-11.52%-26.73M
50.62%-3.34M
-197.21%-17.46M
55.01%-2.25M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-89.65%-8.68M
-35.17%-36.12M
-289.65%-13.03M
44.48%-9.69M
-291.55%-8.83M
-24.80%-4.58M
-11.52%-26.73M
50.62%-3.34M
-197.21%-17.46M
55.01%-2.25M
Basic earnings per share
-80.00%-0.09
17.39%-0.38
-0.14
54.55%-0.1
-125.00%-0.09
78.26%-0.05
69.33%-0.46
0
40.54%-0.22
87.10%-0.04
Diluted earnings per share
-80.00%-0.09
17.39%-0.38
-0.14
54.55%-0.1
-125.00%-0.09
78.26%-0.05
69.33%-0.46
0
40.54%-0.22
87.10%-0.04
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Mar 31, 2026(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 68.99%9.34M32.68%39.7M220.26%13.8M-43.26%10.61M215.95%9.76M44.61%5.53M19.35%29.92M-37.83%4.31M202.59%18.7M-41.64%3.09M
Selling and administrative expenses 12.70%2.33M8.64%7.85M9.60%1.96M0.65%1.89M13.14%1.93M11.67%2.07M-0.92%7.22M9.85%1.79M10.67%1.88M-6.96%1.7M
-General and administrative expense 12.70%2.33M8.64%7.85M9.60%1.96M0.65%1.89M13.14%1.93M11.67%2.07M-0.92%7.22M9.85%1.79M10.67%1.88M-6.96%1.7M
Research and development costs 102.58%7.02M40.33%31.86M370.17%11.84M-48.16%8.72M465.56%7.83M75.50%3.46M27.66%22.7M-52.50%2.52M275.13%16.83M-59.99%1.38M
Operating profit -68.99%-9.34M-32.68%-39.7M-220.26%-13.8M43.26%-10.61M-215.95%-9.76M-44.61%-5.53M-19.35%-29.92M37.83%-4.31M-202.59%-18.7M41.64%-3.09M
Net non-operating interest income expense -45.74%520.14K5.57%3.38M-29.21%682.48K-32.96%833.77K7.57%903.77K529.15%958.52K174.94%3.2M329.00%964.04K328.21%1.24M186.47%840.15K
Non-operating interest income -45.74%520.14K5.57%3.38M-29.21%682.48K-32.96%833.77K7.57%903.77K529.15%958.52K174.94%3.2M329.00%964.04K328.21%1.24M186.47%840.15K
Other net income (expense) 2,256.56%143.09K14,138.59%200.47K2,676.16%96.56K3,978.76%83.47K543.43%27.08K-297.88%-6.64K97.43%-1.43K105.66%3.48K-114.00%-2.15K50.05%-6.11K
Other non- operating income (expenses) 2,256.56%143.09K14,138.59%200.47K2,676.16%96.56K3,978.76%83.47K543.43%27.08K-297.88%-6.64K97.43%-1.43K105.66%3.48K-114.00%-2.15K50.05%-6.11K
Income before tax -89.65%-8.68M-35.17%-36.12M-289.65%-13.03M44.48%-9.69M-291.55%-8.83M-24.80%-4.58M-11.52%-26.73M50.62%-3.34M-197.21%-17.46M55.01%-2.25M
Income tax
Net income -89.65%-8.68M-35.17%-36.12M-289.65%-13.03M44.48%-9.69M-291.55%-8.83M-24.80%-4.58M-11.52%-26.73M50.62%-3.34M-197.21%-17.46M55.01%-2.25M
Net income continuous Operations -89.65%-8.68M-35.17%-36.12M-289.65%-13.03M44.48%-9.69M-291.55%-8.83M-24.80%-4.58M-11.52%-26.73M50.62%-3.34M-197.21%-17.46M55.01%-2.25M
Minority interest income
Net income attributable to the parent company -89.65%-8.68M-35.17%-36.12M-289.65%-13.03M44.48%-9.69M-291.55%-8.83M-24.80%-4.58M-11.52%-26.73M50.62%-3.34M-197.21%-17.46M55.01%-2.25M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -89.65%-8.68M-35.17%-36.12M-289.65%-13.03M44.48%-9.69M-291.55%-8.83M-24.80%-4.58M-11.52%-26.73M50.62%-3.34M-197.21%-17.46M55.01%-2.25M
Basic earnings per share -80.00%-0.0917.39%-0.38-0.1454.55%-0.1-125.00%-0.0978.26%-0.0569.33%-0.46040.54%-0.2287.10%-0.04
Diluted earnings per share -80.00%-0.0917.39%-0.38-0.1454.55%-0.1-125.00%-0.0978.26%-0.0569.33%-0.46040.54%-0.2287.10%-0.04
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions --Unqualified Opinion--------Unqualified Opinion------
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +34.01%
Sample Name
Sample Code
 +27.74%
Sample Name
Sample Code
 +26.87%
4
United States Gasoline Fund Lp
UGA
+26.33%
5
Powershares Db Multi-Sector Commodi Powershares Db Oil Fund
DBO
+20.91%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +11.54%
Sample Name
Sample Code
 +10.70%
Sample Name
Sample Code
 +6.24%
4
NIO Inc
NIO
+4.27%
5
Hesai
HSAI
+3.89%
View More
Middle East conflict spreads to the stock market! How should investors respond?
According to Axios, on Sunday local time, Trump rejected Iran's latest ceasefire proposal, prompting a sharp response from Iran: no one woul Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -